舒心通脉方联合常规西药治疗病毒性心肌炎的疗效及对CMR 参数的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R542.2+1

基金项目:


Therapeutic Effect of Shuxin Tongmai Prescription Combined with Conventional Western Medicine on Viral Myocarditis and Its Influence on CMR Parameters
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察舒心通脉方联合常规西药治疗病毒性心肌炎的疗效及对心脏磁共振成像(CMR) 参数的影响。方法:选取108 例病毒性心肌炎患者,按随机数字表法分为对照组及观察组各54 例。对照组给予抗病毒、营养心肌等常规西药治疗,观察组在对照组基础上给予舒心通脉方治疗。2 组均连续治疗4 周。比较2 组临床疗效,观察2 组治疗前后CMR 参数、中医证候积分,炎症介质[白细胞介素-8(IL-8)、白细胞介素-21(IL-21)、肿瘤坏死因子-α(TNF-α)]、肌酸激酶同工酶(CK-MB)、酸脱氢酶(LDH)、心肌肌钙蛋白T(cTnT)、心肌肌钙蛋白I(cTnI) 心肌酶水平的变化,观察2 组不良反应发生情况。结果:观察组临床疗效总有效率为94.44%,高于对照组81.48%,差异有统计学意义(P<0.05)。治疗后,2 组左心室射血数(LVEF) 均较治疗前升高,左心室舒张末期容积(LVEDV)、左心室收缩末期容积(LVESV) 均较治疗前下降,差异均有统计学意义(P<0.05),每搏输出量(SV)、心输出量(CO)、心脏指数(CI) 与治疗前相比,差异均无统计学意义(P>0.05);治疗后,观察组LVEF 高于对照组,LVEDV、LVESV 均低于对照组,差异均有统计学意义(P<0.05),SV、CO、CI 与对照组治疗后比较,差异均无统计学意义(P>0.05)。治疗后,2 组IL-8、IL-21、TNF-α 水平均较治疗前下降,观察组上述3 项水平均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组CK-MB、LDH、cTnT、cTnI 水平均较治疗前下降,观察组上述4 项水平均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组中医证候积分均较治疗前下降,观察组中医证候积分低于对照组,差异均有统计学意义(P<0.05)。2 组用药期间,患者未发生明显皮疹、胃肠道不适、头痛等不良反应。结论:舒心通脉方联合常规西药治疗病毒性心肌炎可减轻患者心脏受损程度,改善心功能,减轻炎症反应,提高临床疗效。

    Abstract:

    Abstract: Objective: To observe the therapeutic effect of Shuxin Tongmai prescription combined with conventional western medicine on the treatment of viral myocarditis and its influence on parameters of cardiac magnetic resonance imaging (CMR). Methods: A total of 108 patients with viral myocarditis were selected and divided into the control group and the observation group according to random number table method,with 54 cases in each group. The control group was treated with conventional western medicine such as antiviral and nourishing myocardium, while the observation group was additionally treated with Shuxin Tongmai prescription based on the treatment of the control group. Both groups were treated for four weeks. The clinical effects in the two groups were compared. The CMR parameters,Chinese medicine syndrome scores,inflammatory mediators including interleukin- 8(IL-8),interleukin-21(IL-21) and tumor necrosis factor- α(TNF-α), creatine kinase- MB(CK- MB),lactate dehydrogenase(LDH),and levels of myocardial enzymes including cardiac troponin T (cTnT) and cardiac troponin I(cTnI) before and after treatment were observed. The incidence of adverse reactions in both groups was also observed. Results: The total effective rate was 94.44% in the observation group, higher than that of 81.48% in the control group,the difference being significant(P<0.05). After treatment,the including left ventricular ejection fraction(LVEF) levels in both groups were increased when compared with those before treatment(P<0.05),and the levels of left ventricular end- diastolic volume(LVEDV) and left ventricular end systolic volume(LVESV) were decreased(P<0.05),and there was no significant difference in the levels of Stroke Volume(SV),Cardiac Output(CO) and Cardiac Index(CI) between the two groups when compared with those before treatment(P>0.05). After treatment,the LVEF level in the observation group were higher than that in the control group(P<0.05),and the levels of LVEDV and LVESV were lower than those in the control group(P<0.05),and there was no significant difference in the levels of SV,CO and CI between the two groups(P>0.05). After treatment,the levels of IL- 8,IL- 21 and TNF- α in both groups were decreased when compared with those before treatment(P<0.05), and the above three levels in the observation group were lower than those in the control group, differences being significant(P<0.05). After treatment, the levels of CK- MB, LDH, cTnT and cTnI in both groups were decreased when compared with those before treatment(P<0.05),and the above four levels in the observation group were lower than those in the control group, differences being significant(P<0.05). After treatment, the Chinese medicine syndrome scores in both groups were decreased when compared with those before treatment(P<0.05), and the Chinese medicine syndrome score in the observation group was lower than that in the control group,differences being significant(P< 0.05). No obvious rash, gastrointestinal discomfort, headache and other adverse reactions occurred in both groups during medication. Conclusion:The therapy of Shuxin Tongmai prescription combined with conventional western medicine for viral myocarditis can reduce the degree of cardiac damage,improve cardiac function,reduce inflammatory response and improve clinical effect.

    参考文献
    相似文献
    引证文献
引用本文

孙全立.舒心通脉方联合常规西药治疗病毒性心肌炎的疗效及对CMR 参数的影响[J].新中医,2022,54(5):83-87

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-03-10
  • 出版日期: